News Image

DiaCarta Receives U.S. FDA Emergency Use Authorization for its Monkeypox Test Kit

Provided By Globe Newswire

Last update: Jan 12, 2023

PLEASANTON, Calif., Jan. 12, 2023 (GLOBE NEWSWIRE) -- DiaCarta, Ltd. (“DiaCarta”), a precision molecular diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) granted Emergency Use Authorization (EUA) for its QuantiVirusTM MPXV test, which is a PCR test for the qualitative detection of DNA from monkeypox virus (MPXV) in lesion swabs collected from individuals suspected of monkeypox infection.

Read more at globenewswire.com
Follow ChartMill for more